Thyroxine



Indications and Reactions:

Role Indications Reactions
Primary
Hypothyroidism 75.0%
Primary Hypothyroidism 25.0%
Supraventricular Extrasystoles 50.0%
Foetal Heart Rate Deceleration Abnormality 25.0%
Weight Increased 25.0%
Secondary
Drug Use For Unknown Indication 19.5%
Product Used For Unknown Indication 16.5%
Asthma 13.4%
Hypothyroidism 12.8%
Migraine 5.5%
Osteoarthritis 5.5%
Depression 3.7%
Major Depression 3.0%
Ill-defined Disorder 2.4%
Immunosuppressant Drug Therapy 2.4%
Arthritis 1.8%
Deep Vein Thrombosis 1.8%
Epilepsy 1.8%
Hypercholesterolaemia 1.8%
Insomnia 1.8%
Anxiety 1.2%
Bursitis 1.2%
Chronic Obstructive Pulmonary Disease 1.2%
Gastrooesophageal Reflux Disease 1.2%
Hypertension 1.2%
Loss Of Consciousness 25.0%
Dyspnoea 8.3%
Skin Papilloma 8.3%
Haemoptysis 5.6%
Polyneuropathy 5.6%
Tremor 5.6%
Urinary Tract Infection 5.6%
Blood Thyroid Stimulating Hormone Increased 2.8%
Cerebral Haemorrhage 2.8%
Gestational Diabetes 2.8%
Hyperkalaemia 2.8%
Oedema 2.8%
Palpitations 2.8%
Pancreatitis 2.8%
Pneumonia 2.8%
Pruritus 2.8%
Pruritus Generalised 2.8%
Skin Burning Sensation 2.8%
Status Epilepticus 2.8%
Throat Tightness 2.8%
Concomitant
Product Used For Unknown Indication 25.7%
Drug Use For Unknown Indication 20.0%
Rheumatoid Arthritis 9.0%
Hypothyroidism 8.5%
Hypertension 6.3%
Depression 3.1%
Thyroid Disorder 2.8%
Pain 2.7%
Primary Hypothyroidism 2.5%
Diabetes Mellitus 2.3%
Osteoporosis 2.3%
Acth Decreased 2.2%
Breast Cancer 2.0%
Hypopituitarism 1.8%
Myocardial Ischaemia 1.7%
Atrial Fibrillation 1.6%
Blood Cholesterol Increased 1.5%
Schizophrenia 1.5%
Systemic Lupus Erythematosus 1.4%
Epilepsy 1.3%
Vomiting 13.3%
Weight Decreased 8.2%
Respiratory Failure 6.4%
Syncope 6.4%
Urinary Tract Infection 6.4%
Dyspnoea 4.7%
Renal Impairment 4.7%
Visual Acuity Reduced 4.7%
Malaise 4.3%
Pyrexia 4.3%
Swelling Face 4.3%
Paraesthesia 3.9%
Weight Increased 3.9%
Withdrawal Syndrome 3.9%
Death 3.4%
Nausea 3.4%
Pain 3.4%
Pain In Extremity 3.4%
Pituitary Tumour 3.4%
Pulmonary Embolism 3.4%
Interacting
Drug Use For Unknown Indication 71.4%
Obesity 14.3%
Abdominal Pain Upper 4.8%
Bladder Disorder 4.8%
Post Procedural Hypothyroidism 4.8%
Psychiatric Symptom 33.3%
Inhibitory Drug Interaction 16.7%
Psychotic Disorder 16.7%
Temperature Intolerance 16.7%
Weight Increased 16.7%